In a prostate cancer study, high levels of a 79 bp fragment of the mtDNA 16 S rRNA gene in serum correlated with prostate-specific antigen recurrence/progression, suggesting circulating mtDNA levels can be used as an independent prognostic prostate cancer biomarker (136). The gene discussed is KLK3; the disease is prostate cancer.